Press Room

Acella Pharmaceuticals Signs Product Development Agreement with Catalent To Bring Opioid-Abuse Deter11-Aug-2017

ATLANTA – (Aug. 10, 2017) – Acella Pharmaceuticals, LLC, a leading U.S. manufacturer of specialty pharmaceuticals across several ther..

Acella Pharmaceuticals, LLC, announces approval of generic to VituzĀ® Oral Solution27-Jul-2017

ATLANTA (July 27, 2017) - Acella Pharmaceuticals, LLC, a leading U.S. developer of specialty pharmaceuticals across several therapeutic categorie..

Acella Pharmaceuticals, LLC, announces approval of a generic Bromfed antihistamine/decongestant07-Nov-2016

ATLANTA (Oct. 28, 2016) - Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, recently secured approval for a sugar-free bioequivale..

Acella Pharmaceuticals, LLC, Announces Approval and Launch of Loutrex Topical Cream31-Jan-2014

ATLANTA (Jan. 31, 2014) – Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, recently announced the approval and launch of Lo..

Avion Pharmaceuticals, LLC., Launches Prenate Mini30-Jul-2012

ATLANTA (July 24, 2012) - Avion Pharmaceuticals, a specialty pharmaceutical company, announces the launch of Prenate Mini, the newest addition to..

Acella Pharmaceuticals, LLC, files abbreviated new drug application (ANDA) With the U.S. Food & 21-Feb-2012

ATLANTA (Feb. 21, 2012) - Acella Pharmaceuticals, LLC, recently announced that it has filed an abbreviated new drug application (ANDA) for a prod..

Acella Pharmaceuticals, LLC Names Allen Fields as new VP, Head of R&D15-Feb-2012

ATLANTA (Feb. 15, 2012) - Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, recently announced the appointment of Allen Fields, Dr..

Acella Pharmaceuticals, LLC Announces Its Acquisition of the PRENATEĀ® Family of Trademarks and Assoc05-Jan-2012

ATLANTA (Jan. 5, 2012) - Acella Pharmaceuticals, LLC announced its acquisition of the PRENATE® family of trademarks and other associated inte..

Acella Pharmaceuticals Signs License Agreement for U.S. Marketing Rights to Generic Antibiotic07-Jun-2010

ALPHARETTA (June 7, 2010) – Acella Pharmaceuticals has signed a licensing agreement for the U.S. marketing rights to a generic version of a..

Brookstone Pharmaceuticals, LLC becomes Acella Pharmaceuticals, LLC16-Nov-2009

ALPHARETTA, Ga. (November 16, 2009) - Brookstone Pharmaceuticals, an emerging specialty pharmaceutical company, announced today its decision to c..

TEST-right

Contact Us

Please fill out the form below.

678.325.5189

11675 Great Oaks Way, Suite 144
Alpharetta, GA 30022
Privacy Policy | Terms & Conditions
© 2016 Acella Pharmaceuticals, LLC
Site forged by Liquid Anvil